H28.1 H06.2
Conditions
Interventions
Group 1: Patients who have received ocular irradiation as part of treatment for endocrine orbitopathy.
Group 2: Control group: patients attending our University Hospital of Ophthalmology for regular e
Sponsors
Carl von Ossietzky Universität Oldenburg
Eligibility
Sex/Gender
All
Age
20 Years to 90 Years
Inclusion criteria
Inclusion criteria: Patients after orbital irradiation at the Pius Hospital in Oldenburg due to endocrine orbitopathy from all age groups. The control group consists of age-matched patients who come for ophthalmologic treatment to the University Outpatient Clinic for Ophthalmology at the Pius Hospital and agree to participate voluntarily in the study.
Exclusion criteria
Exclusion criteria: Implantation of an artificial lens in the past, diabetes mellitus, severe ocular trauma in the past, uveitis in the past and patients after pars plana vitrectomy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The lens of the eye of patients after irradiation, and the eye lenses of a control group will be examined with the Pentacam. At the end it will be determined how the lens changes can be quantified with the Pentacam. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measurements are taken using Pentacam and subjectively using a scale (LOCS III). In addition, the participants receive a questionnaire. | — |
Countries
Germany
Contacts
Public ContactTim Ahmels
Universitätsklinik für Augenheilkunde, Pius Hospital Oldenburg
Outcome results
None listed